Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures
- Autores
- Bispo, Daniela; Fabris, Victoria Teresa; Lamb, Caroline Ana; Lanari, Claudia Lee Malvina; Helguero, Luisa Alejandra; Gil, Ana M.
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- The metabolic characteristics of metastatic and non-metastatic breast carcinomas remain poorly studied. In this work, untargeted Nuclear Magnetic Resonance (NMR) metabolomics was used to compare two medroxyprogesterone acetate (MPA)-induced mammary carcinomas lines with different metastatic abilities. Different metabolic signatures distinguished the non-metastatic (59-2-HI) and the metastatic (C7-2-HI) lines, with glucose, amino acid metabolism, nucleotide metabolism and lipid metabolism as the major affected pathways. Non-metastatic tumours appeared to be characterised by: (a) reduced glycolysis and tricarboxylic acid cycle (TCA) activities, possibly resulting in slower NADH biosynthesis and reduced mitochondrial transport chain activity and ATP synthesis; (b) glutamate accumulation possibly related to reduced glutathione activity and reduced mTORC1 activity; and (c) a clear shift to lower phosphoscholine/glycerophosphocholine ratios and sphingomyelin levels. Within each tumour line, metabolic profiles also differed significantly between tumours (i.e., mice). Metastatic tumours exhibited marked inter-tumour changes in polar compounds, some suggesting different glycolytic capacities. Such tumours also showed larger intra-tumour variations in metabolites involved in nucleotide and cholesterol/fatty acid metabolism, in tandem with less changes in TCA and phospholipid metabolism, compared to non-metastatic tumours. This study shows the valuable contribution of untargeted NMR metabolomics to characterise tumour metabolism, thus opening enticing opportunities to find metabolic markers related to metastatic ability in endocrine breast cancer.
Fil: Bispo, Daniela. Universidade de Aveiro; Portugal
Fil: Fabris, Victoria Teresa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Lamb, Caroline Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Lanari, Claudia Lee Malvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Helguero, Luisa Alejandra. Universidade de Aveiro; Portugal
Fil: Gil, Ana M.. Universidade de Aveiro; Portugal - Materia
-
NMR
ENDOCRINE BREAST CANCER
HORMONE-INDEPENDENT GROWTH
MEDROXYPROGESTERONE ACETATE
METABOLISM
METABOLOMICS
METASTATIC POTENTIAL
MURINE MODELS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/132524
Ver los metadatos del registro completo
id |
CONICETDig_4e4c1c1ffa3acc5f894b7869902ae6bf |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/132524 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signaturesBispo, DanielaFabris, Victoria TeresaLamb, Caroline AnaLanari, Claudia Lee MalvinaHelguero, Luisa AlejandraGil, Ana M.NMRENDOCRINE BREAST CANCERHORMONE-INDEPENDENT GROWTHMEDROXYPROGESTERONE ACETATEMETABOLISMMETABOLOMICSMETASTATIC POTENTIALMURINE MODELShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3The metabolic characteristics of metastatic and non-metastatic breast carcinomas remain poorly studied. In this work, untargeted Nuclear Magnetic Resonance (NMR) metabolomics was used to compare two medroxyprogesterone acetate (MPA)-induced mammary carcinomas lines with different metastatic abilities. Different metabolic signatures distinguished the non-metastatic (59-2-HI) and the metastatic (C7-2-HI) lines, with glucose, amino acid metabolism, nucleotide metabolism and lipid metabolism as the major affected pathways. Non-metastatic tumours appeared to be characterised by: (a) reduced glycolysis and tricarboxylic acid cycle (TCA) activities, possibly resulting in slower NADH biosynthesis and reduced mitochondrial transport chain activity and ATP synthesis; (b) glutamate accumulation possibly related to reduced glutathione activity and reduced mTORC1 activity; and (c) a clear shift to lower phosphoscholine/glycerophosphocholine ratios and sphingomyelin levels. Within each tumour line, metabolic profiles also differed significantly between tumours (i.e., mice). Metastatic tumours exhibited marked inter-tumour changes in polar compounds, some suggesting different glycolytic capacities. Such tumours also showed larger intra-tumour variations in metabolites involved in nucleotide and cholesterol/fatty acid metabolism, in tandem with less changes in TCA and phospholipid metabolism, compared to non-metastatic tumours. This study shows the valuable contribution of untargeted NMR metabolomics to characterise tumour metabolism, thus opening enticing opportunities to find metabolic markers related to metastatic ability in endocrine breast cancer.Fil: Bispo, Daniela. Universidade de Aveiro; PortugalFil: Fabris, Victoria Teresa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Lamb, Caroline Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Lanari, Claudia Lee Malvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Helguero, Luisa Alejandra. Universidade de Aveiro; PortugalFil: Gil, Ana M.. Universidade de Aveiro; PortugalMDPI AG2020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/132524Bispo, Daniela; Fabris, Victoria Teresa; Lamb, Caroline Ana; Lanari, Claudia Lee Malvina; Helguero, Luisa Alejandra; et al.; Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures; MDPI AG; Biomolecules; 10; 9; 2020; 1-192218-273X2218-273XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2218-273X/10/9/1242info:eu-repo/semantics/altIdentifier/doi/10.3390/biom10091242info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:56:52Zoai:ri.conicet.gov.ar:11336/132524instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:56:53.325CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
title |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
spellingShingle |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures Bispo, Daniela NMR ENDOCRINE BREAST CANCER HORMONE-INDEPENDENT GROWTH MEDROXYPROGESTERONE ACETATE METABOLISM METABOLOMICS METASTATIC POTENTIAL MURINE MODELS |
title_short |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
title_full |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
title_fullStr |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
title_full_unstemmed |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
title_sort |
Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures |
dc.creator.none.fl_str_mv |
Bispo, Daniela Fabris, Victoria Teresa Lamb, Caroline Ana Lanari, Claudia Lee Malvina Helguero, Luisa Alejandra Gil, Ana M. |
author |
Bispo, Daniela |
author_facet |
Bispo, Daniela Fabris, Victoria Teresa Lamb, Caroline Ana Lanari, Claudia Lee Malvina Helguero, Luisa Alejandra Gil, Ana M. |
author_role |
author |
author2 |
Fabris, Victoria Teresa Lamb, Caroline Ana Lanari, Claudia Lee Malvina Helguero, Luisa Alejandra Gil, Ana M. |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
NMR ENDOCRINE BREAST CANCER HORMONE-INDEPENDENT GROWTH MEDROXYPROGESTERONE ACETATE METABOLISM METABOLOMICS METASTATIC POTENTIAL MURINE MODELS |
topic |
NMR ENDOCRINE BREAST CANCER HORMONE-INDEPENDENT GROWTH MEDROXYPROGESTERONE ACETATE METABOLISM METABOLOMICS METASTATIC POTENTIAL MURINE MODELS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
The metabolic characteristics of metastatic and non-metastatic breast carcinomas remain poorly studied. In this work, untargeted Nuclear Magnetic Resonance (NMR) metabolomics was used to compare two medroxyprogesterone acetate (MPA)-induced mammary carcinomas lines with different metastatic abilities. Different metabolic signatures distinguished the non-metastatic (59-2-HI) and the metastatic (C7-2-HI) lines, with glucose, amino acid metabolism, nucleotide metabolism and lipid metabolism as the major affected pathways. Non-metastatic tumours appeared to be characterised by: (a) reduced glycolysis and tricarboxylic acid cycle (TCA) activities, possibly resulting in slower NADH biosynthesis and reduced mitochondrial transport chain activity and ATP synthesis; (b) glutamate accumulation possibly related to reduced glutathione activity and reduced mTORC1 activity; and (c) a clear shift to lower phosphoscholine/glycerophosphocholine ratios and sphingomyelin levels. Within each tumour line, metabolic profiles also differed significantly between tumours (i.e., mice). Metastatic tumours exhibited marked inter-tumour changes in polar compounds, some suggesting different glycolytic capacities. Such tumours also showed larger intra-tumour variations in metabolites involved in nucleotide and cholesterol/fatty acid metabolism, in tandem with less changes in TCA and phospholipid metabolism, compared to non-metastatic tumours. This study shows the valuable contribution of untargeted NMR metabolomics to characterise tumour metabolism, thus opening enticing opportunities to find metabolic markers related to metastatic ability in endocrine breast cancer. Fil: Bispo, Daniela. Universidade de Aveiro; Portugal Fil: Fabris, Victoria Teresa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Lamb, Caroline Ana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Lanari, Claudia Lee Malvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Helguero, Luisa Alejandra. Universidade de Aveiro; Portugal Fil: Gil, Ana M.. Universidade de Aveiro; Portugal |
description |
The metabolic characteristics of metastatic and non-metastatic breast carcinomas remain poorly studied. In this work, untargeted Nuclear Magnetic Resonance (NMR) metabolomics was used to compare two medroxyprogesterone acetate (MPA)-induced mammary carcinomas lines with different metastatic abilities. Different metabolic signatures distinguished the non-metastatic (59-2-HI) and the metastatic (C7-2-HI) lines, with glucose, amino acid metabolism, nucleotide metabolism and lipid metabolism as the major affected pathways. Non-metastatic tumours appeared to be characterised by: (a) reduced glycolysis and tricarboxylic acid cycle (TCA) activities, possibly resulting in slower NADH biosynthesis and reduced mitochondrial transport chain activity and ATP synthesis; (b) glutamate accumulation possibly related to reduced glutathione activity and reduced mTORC1 activity; and (c) a clear shift to lower phosphoscholine/glycerophosphocholine ratios and sphingomyelin levels. Within each tumour line, metabolic profiles also differed significantly between tumours (i.e., mice). Metastatic tumours exhibited marked inter-tumour changes in polar compounds, some suggesting different glycolytic capacities. Such tumours also showed larger intra-tumour variations in metabolites involved in nucleotide and cholesterol/fatty acid metabolism, in tandem with less changes in TCA and phospholipid metabolism, compared to non-metastatic tumours. This study shows the valuable contribution of untargeted NMR metabolomics to characterise tumour metabolism, thus opening enticing opportunities to find metabolic markers related to metastatic ability in endocrine breast cancer. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/132524 Bispo, Daniela; Fabris, Victoria Teresa; Lamb, Caroline Ana; Lanari, Claudia Lee Malvina; Helguero, Luisa Alejandra; et al.; Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures; MDPI AG; Biomolecules; 10; 9; 2020; 1-19 2218-273X 2218-273X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/132524 |
identifier_str_mv |
Bispo, Daniela; Fabris, Victoria Teresa; Lamb, Caroline Ana; Lanari, Claudia Lee Malvina; Helguero, Luisa Alejandra; et al.; Hormone-independent mouse mammary adenocarcinomas with different metastatic potential exhibit different metabolic signatures; MDPI AG; Biomolecules; 10; 9; 2020; 1-19 2218-273X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.mdpi.com/2218-273X/10/9/1242 info:eu-repo/semantics/altIdentifier/doi/10.3390/biom10091242 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
MDPI AG |
publisher.none.fl_str_mv |
MDPI AG |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269429249867776 |
score |
13.13397 |